Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G V Quinnan

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Journal of Virology|July 1, 1987
Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccineK S Chen, D B Burlington, G V Quinnan
AIDS (London, England)|April 1, 1988
Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigensD H Shepp, F Daguillard, D Mann, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1987
The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccineM C Anderson, H Baer, D J Frazier, et al.
Journal of Virology|February 7, 2001
A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complexE J Park, M K Gorny, S Zolla-Pazner, et al.
Infection|January 1, 1985
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
Journal of Virology|July 10, 1999
Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolatesD J Chabot, P F Zhang, G V Quinnan, et al.
Biochimica Et Biophysica Acta|February 28, 1988
Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gagC J Marcus-Sekura, A M Woerner, M Klutch, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitroJ F Manischewitz, G V Quinnan, H C Lane, et al.
Infection|July 1, 1984
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
Journal of Biological Standardization|April 1, 1989
Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodiesC Singer, F Knauert, G Bushar, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Journal of Virology|July 1, 1987
Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccineK S Chen, D B Burlington, G V Quinnan
AIDS (London, England)|April 1, 1988
Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigensD H Shepp, F Daguillard, D Mann, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1987
The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccineM C Anderson, H Baer, D J Frazier, et al.
Journal of Virology|February 7, 2001
A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complexE J Park, M K Gorny, S Zolla-Pazner, et al.
Infection|January 1, 1985
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
Journal of Virology|July 10, 1999
Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolatesD J Chabot, P F Zhang, G V Quinnan, et al.
Biochimica Et Biophysica Acta|February 28, 1988
Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gagC J Marcus-Sekura, A M Woerner, M Klutch, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitroJ F Manischewitz, G V Quinnan, H C Lane, et al.
Infection|July 1, 1984
Interleukin 2 therapy in infectious diseases: rationale and prospectsJ P Siegel, A H Rook, J Y Djeu, et al.
Journal of Biological Standardization|April 1, 1989
Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodiesC Singer, F Knauert, G Bushar, et al.
Pageof 8